Triemta Tablets x 30

Triemta Tablets contain a combination of three active ingredients: Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate. This combination medication is primarily used for the treatment of HIV-1 infection in adults and adolescents aged 12 years and older.

Detailed Description of Active Ingredients:

1. Efavirenz: It belongs to a class of drugs known as non-nucleoside reverse transcriptase inhibitors (NNRTIs). Efavirenz works by inhibiting the reverse transcriptase enzyme, which is essential for the replication of the HIV virus. By blocking this enzyme, it helps to reduce the viral load and slow down the progression of HIV infection.
2. Emtricitabine: It is a nucleoside reverse transcriptase inhibitor (NRTI) that also inhibits the reverse transcriptase enzyme. Emtricitabine works by interfering with the replication process of the virus, thus reducing its ability to multiply and infect new cells.
3. Tenofovir Disoproxil Fumarate: It is another NRTI that works by inhibiting the reverse transcriptase enzyme. Tenofovir Disoproxil Fumarate helps to suppress viral replication and reduce the viral load in the body.

Dosage and Usage Information:

The recommended dosage of Triemta Tablets is one tablet taken orally once daily, preferably at bedtime, on an empty stomach. It is important to follow the prescribed dosage and instructions provided by your healthcare provider.

It is advisable to take Triemta Tablets consistently and at the same time each day to maintain a steady level of the medication in your system. Do not skip doses or stop taking the medication without consulting your healthcare provider, as this may lead to a decrease in its effectiveness and the development of drug resistance.

Precautions and Warnings:

1. Resistance Development: Like all antiretroviral medications, Triemta Tablets should be used in combination with other antiretroviral drugs to reduce the risk of developing drug resistance. It is important to take all prescribed medications as directed and to follow up with your healthcare provider regularly to monitor your viral load and treatment response.
2. Adverse Effects: Triemta Tablets may cause certain side effects. Common side effects include dizziness, headache, nausea, diarrhea, trouble sleeping, and abnormal dreams. These side effects are usually temporary and may improve over time. However, if they persist or become bothersome, it is recommended to inform your healthcare provider.
3. Drug Interactions: Triemta Tablets may interact with other medications, including over-the-counter drugs, supplements, and herbal products. Inform your healthcare provider about all the medications you are currently taking to avoid potential drug interactions.
4. Pregnancy and Breastfeeding: Triemta Tablets should be used with caution during pregnancy. It is important to discuss the potential risks and benefits of the medication with your healthcare provider if you are pregnant or planning to become pregnant. Additionally, the components of Triemta Tablets may pass into breast milk, so it is important to consult your healthcare provider regarding its use during breastfeeding.

It is crucial to adhere to your prescribed treatment regimen, attend regular medical appointments, and communicate openly with your healthcare provider to ensure the optimal management of your HIV infection.